Kalaris Therapeutics, Inc. (KLRS) › Net IncomeKalaris Therapeutics, Inc. (KLRS) — Net IncomeAnnual figures by period end, from SEC filings.2019-12-31: -$23.84M2020-12-31: -$69.78M2021-12-31: -$171.96M2022-12-31: -$168.71M2023-12-31: -$190.42M2024-12-31: -$69.17M2025-12-31: -$43.44M-$43.44M2019-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$43.44M—2026-03-17From 2025-01-012024-12-31-$69.17M—2026-03-17From 2024-01-012023-12-31-$190.42M—2025-03-07From 2023-01-012022-12-31-$168.71M—2024-03-15From 2022-01-012021-12-31-$171.96M—2023-02-15From 2021-01-012020-12-31-$69.78M—2022-02-10From 2020-01-012019-12-31-$23.84M—2021-02-12From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)